Available clinical evidence supports the strategy to always consider intermittent catheterization as the first therapeutic choice, before considering the use of an indwelling catheter.
Intermittent catheterization is the first therapeutic choice and is a safer bladder management method than both urethral and suprapubic indwelling catheters. Intermittent catheterization is central to reduce morbidity related to renal failure and neurogenic bladder dysfunction.
